Emcure Pharmaceuticals Limited IPO is set to launch on 3 July, 2024. The company initiated its business operations in the year 1981. It is involved in the business of manufacturing and developing pharmaceutical products. It holds 13th rank for domestic sales in India and has a ranking of 4th in coverage of market share. The Key area of the company’s sales is HIV and gynaecology. It has 552 scientists and 5 operational research facilities across India. The company has 102 drug master files, 33 pending patents approvals and 201 granted patents. It has 13 manufacturing facilities across India and a network of 5000 field personnels, 37 carry and forward agents and more than 5000 stockists.
Emcure Pharmaceuticals Limited IPO DETAILS
Emcure Pharmaceuticals Limited IPO is set to launch on 3 July, 2024. The subscription timeline extends till 5 July, 2024. The size for the IPO is Rs. 1952.03 Crore. Shares issued through fresh issue mode are worth Rs 800 Crore. Shares issued through offer for sale mode are worth Rs 1152.03 Crore. The lot size is 14 shares and the price is Rs. 960 to Rs. 1008 per share. The company is going to get listed at BSE and NSE. The face value per share is Rs.10 and this is a Book Built Issue. The registrar for the company is Link Intime India Private Limited.
Tabular Description of Emcure Pharmaceuticals Limited IPO
| IPO OPENING DATE | 3 July, 2024 |
| CLOSING DATE FOR IPO | 5 July, 2024 |
| ISSUE TYPE | Book Built Issue |
| Face Value per share | Rs. 10 per share |
| IPO price band | Rs. 900 to Rs. 1008 per share |
| LOT SIZE | 14 shares |
| MINIMUM ORDER QUANTITY | 14 shares |
| ISSUE SIZE | Rs. 1952.03 Crore |
| OFFER FOR SALE | Rs. 1152.03 Crore |
| FRESH ISSUE | Rs. 800 Crore |
| LISTING AT | BSE & NSE |
| LISTING DATE | 10 July, 2024 |
Emcure Pharmaceuticals Limited IPO: IMPORTANT DATES
| IPO OPENING DATE | 3 July, 2024 |
| CLOSING DATE FOR IPO | 5 July, 2024 |
| IPO ALLOTMENT DATE | 8 July, 2024 |
| REFUNDS | 9 July, 2024 |
| DEMAT A/C CREDITED ON | 9 July, 2024 |
| IPO LISTING DATE | 10 July, 2024 |
Emcure Pharmaceuticals Limited IPO begins for subscription from 3 July 2024. The IPO subscription would continue till 5 July, 2024. The allotment status for the shareholders who applied would come on 8 July, 2024. The refunds for the ones who did not get allotment would be initiated on 9 July, 2024. The DEMAT accounts of shareholders would be credited on 9 July, 2024. The listing of the company would be completed on 10 July, 2024.
Emcure Pharmaceuticals Limited IPO: Lead Managers
The lead managers are :
- Axis Capital Limited
- Kotak Mahindra Capital Company Limited
- Jefferies India Private Limited
- J.P. Morgan India Private Limited
The minimum lot size for retail investors is 14 shares, amounting to Rs. 14112. The maximum lot size for retail investors is 196 shares, amounting to Rs. 197568. The minimum and maximum lot size for S-HNI and B-HNI are as under:
| Lots | Shares | Amount | |
| Retail (Minimum) | 1 | 14 shares | Rs. 14112 |
| Retail (Maximum) | 13 | 196 shares | Rs. 197568 |
| S-HNI (Minimum) | 14 | 210 shares | Rs. 211680 |
| S-HNI (Maximum) | 67 | 980 shares | Rs. 987840 |
| B-HNI (Maximum) | 68 | 994 shares | Rs. 1001952 |
OBJECTIVES FOR THE IPO
- The IPO money will be used for payment of outstanding liabilities.
- General corporate purposes.
COMPANY FINANCIALS
| Particularly (in Rs. Crore) | 2021-22 | 2022-23 | 2023-24 | |
| Asset | 6063.4 | 6672.5 | 7806.1 | |
| Revenue | 5918.8 | 6031.7 | 6715.2 | |
| PAT | 702.5 | 561.8 | 527.6 |
Emcure Pharmaceuticals Limited had an asset base of 6063 Crore Rs in 2021 which increased to 6672 Crore Rs in 2022 and 7806 Crore Rs in 2023. The revenue of the company was at 5918 Crore Rs in 2021, 6031 Crore Rs in 2022 and 6715 Crore Rs in 2023. Company’s profit in 2021 was 702 Crore Rs, 561 Crore Rs in 2022 and 527 Crore Rs in 2023.
PROS
- It holds 13th rank for domestic sales in India and has a ranking of 4th in coverage of market share.
- The Key area of the company’s sales is HIV and gynaecology. It has 552 scientists and 5 operational research facilities across India.
- The company has 102 drug master files, 33 pending patents approvals and 201 granted patents.
- It has 13 manufacturing facilities across India and a network of 5000 field personnels, 37 carry and forward agents and more than 5000 stockists.
Emcure Pharmaceuticals Limited IPO Application Process with Zerodha
It is very easy to apply for an IPO now if you have a DEMAT account with Zerodha. Follow the steps below for the same :
- Logging into Zerodha console through its website or KITE platform. Clicking the IPO section present in the ORDER tab.
- Click the Emcure Pharmaceuticals Limited IPO button and press the BID button.
- Entering the details asked for like UPI ID, Quantity and price.
- Submit the application form for the IPO.
- Visiting the application of UPI for approving the transaction.
Now, applying for an IPO online is possible with most of the Discount and online brokers.
